Skip to main content
. 2024 Apr 25;19(4):e0302274. doi: 10.1371/journal.pone.0302274

Fig 1. Overview of cohorts.

Fig 1

A) Overview of the development cohort. A total of 185 colorectal cancer (CRC) samples were analyzed. Forty of these samples were tested on a total of three extraction method and two different real-time PCR instruments. Thirty of the samples were analyzed in a total of five laboratories (1; Locarno, 2; Legnano, 3; Novara, 4; Candiolo, and 5; Terni). B) The validation cohort covered 127 CRC samples distributed in four laboratories.